New research reveals that a history of treated syphilis before pregnancy significantly increases the risk of congenital syphilis in newborns. This finding challenges the long-held assumption that prior successful treatment provides long-term protection. Instead, the study highlights a critical window for reinfection that health systems must address with more rigorous surveillance.

Understanding Risks After Being Treated Syphilis Before Pregnancy

The retrospective cohort study, conducted between 2015 and 2023, analyzed over 57,000 pregnancies. Researchers found that women with a history of adequately treated syphilis before pregnancy had a 6.8% rate of congenital syphilis. In contrast, those with no history had a rate of only 0.1%. This represents an adjusted odds ratio (aOR) of 19.61. Consequently, these individuals are nearly twenty times more likely to deliver an infant with the condition.

Moreover, the risk of maternal reinfection during pregnancy is exceptionally high. Roughly 17.8% of mothers with prior syphilis were reinfected, compared to just 0.4% of those without a history. This stark difference indicates that behavioral or environmental risk factors persist beyond initial treatment. Therefore, clinicians must prioritize screening throughout the entire gestational period for this specific group.

Clinical Implications for Enhanced Surveillance

Because the risk of treated syphilis before pregnancy leading to congenital outcomes is so high, current screening protocols may need adjustments. Simply documenting a prior cure is not enough to ensure fetal safety. Healthcare providers should consider frequent serologic testing, especially in regions with high prevalence. Additionally, partner notification and treatment remain essential components of preventing maternal reinfection.

Furthermore, the study emphasizes that prior treatment does not grant biological immunity. The dramatic rise in congenital syphilis cases underscores the need for a \"high-risk\" designation for these patients. By implementing targeted surveillance, the medical community can better identify new infections early and provide timely intervention with penicillin-G.

Frequently Asked Questions

Does a prior cure for syphilis protect against congenital syphilis in future pregnancies?

No, prior treatment does not provide immunity. Mothers who were adequately treated before pregnancy remain at a nearly 20-fold higher risk for congenital syphilis, primarily due to the high rate of reinfection.

Why is the risk so much higher for women with a history of syphilis?

The increased risk is largely driven by maternal reinfection during pregnancy. Statistics show that women with a history of syphilis are nearly 12 times more likely to be reinfected than those without such a history.

Disclaimer: This content is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Toppin JD et al. History of Treated Syphilis Before Pregnancy and Risk of Congenital Syphilis. Obstet Gynecol. 2026 May 08. doi: 10.1097/AOG.0000000000006314. PMID: 42096714.

Centers for Disease Control and Prevention. Sexually Transmitted Infections Surveillance 2022. 2024.

World Health Organization. Mother-to-child transmission of syphilis. December 2024.